» Articles » PMID: 2043773

Recombinant Interferon Alpha in the Treatment of Polycythemia Vera

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 1991 Jun 15
PMID 2043773
Citations 5
Authors
Affiliations
Soon will be listed here.
Citing Articles

Clinical outcomes of interferon therapy for polycythemia vera and essential thrombocythemia: a systematic review and meta-analysis.

Gu W, Yang R, Xiao Z, Zhang L Int J Hematol. 2021; 114(3):342-354.

PMID: 34091876 DOI: 10.1007/s12185-021-03171-1.


Where to Turn for Second-Line Cytoreduction After Hydroxyurea in Polycythemia Vera?.

Nazha A, Gerds A Oncologist. 2016; 21(4):475-80.

PMID: 26975864 PMC: 4828120. DOI: 10.1634/theoncologist.2015-0380.


Possible selective effects of interferon alpha-2b on a malignant clone in a case of polycythemia vera.

Hino M, Futami E, Okuno S, Miki T, Nishizawa Y, Morii H Ann Hematol. 1993; 66(3):161-2.

PMID: 8471662 DOI: 10.1007/BF01697629.


A prospective comparison between treatment with phlebotomy alone and with interferon-alpha in patients with polycythemia vera.

Sacchi S, Leoni P, Liberati M, Riccardi A, Tabilio A, Tartoni P Ann Hematol. 1994; 68(5):247-50.

PMID: 8018766 DOI: 10.1007/BF01737425.


Polycythemia vera--a climatological disease.

BERLIN N Trans Am Clin Climatol Assoc. 1994; 106:25-36; discussion 36-7.

PMID: 7483176 PMC: 2376523.